FDA and EMA Align on Ten Principles to Guide Artificial Intelligence Use in Drug Development - appliedclinicaltrialsonline.com
FDA and EMA have established ten guiding principles for the use of AI in drug development, impacting compliance and operational standards for related businesses.
Aforeworn detected this change in the Healthcare AI Regulation (FDA / ONC) space on September 2, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Health tech startups, medical device companies, and health systems involved in drug development. should confirm how it applies to their specific situation before acting. There is a time constraint attached: No specific deadline stated.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Healthcare AI Regulation (FDA / ONC) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Introduction of ten principles guiding the use of AI in drug development, which may affect compliance and operational practices.
Who it affects
Health tech startups, medical device companies, and health systems involved in drug development.
What you must do
Review and align current AI practices with the newly established principles to ensure compliance.
Deadline
No specific deadline stated.
Never miss a change like this again
Aforeworn watches Healthcare AI Regulation (FDA / ONC) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Healthcare AI Regulation (FDA / ONC)
- FDA Requests Feedback on Considerations for Generative AI-Enabled Medical Devices Regulation - advocacy.sba.gov
- Indiana passes law threatening non-profit status of expensive hospitals - The Guardian
- State Auditor’s office takes action against ‘misleading’ healthcare plans - dailymontanan.com
- NetChoice Testimony in Opposition to Kansas SB 405, An Act Concerning Artificial Intelligence - netchoice.org
- House Bill 945 — AI medical services (-6) - idahofreedom.org